Cofoe Medical Technology Co

Cofoe Medical Technology Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Cofoe Medical Technology Co (301087.SZ) as of Oct 23, 2026 is 139.29 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 174.14 % — a change of -20.01% (lower).

FCF Conversion

139.29 %

YoY

-20.01%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Cofoe Medical Technology Co is 2025 139.29 % . FCF Conversion Rate (FCF/EBITDA) of Cofoe Medical Technology Co was 2024 174.14 % . It decreases by -20.01% lower compared to the previous year.

The Cofoe Medical Technology Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-35.31 CNY
Jan 1, 2019
-38.82 CNY
Jan 1, 2020
28.82 CNY
Jan 1, 2021
-63.72 CNY
Jan 1, 2022
-179.29 CNY
Jan 1, 2023
8.10 CNY
Jan 1, 2024
174.14 CNY
Jan 1, 2025
139.29 CNY
The Cofoe Medical Technology Co FCF Conversion history
YEARFCF ConversionYoY
139.29 %-20.01%
174.14 %+2,049.78%
8.10 %-104.52%
-179.29 %+181.38%
-63.72 %-321.06%
28.82 %-174.25%
-38.82 %+9.95%
-35.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cofoe Medical Technology Co Stock analysis

What does Cofoe Medical Technology Co do? Cofoe Medical Technology Co., Ltd. generates revenue through the research, development, manufacture, and sale of medical equipment under the Cofoe brand. The company offers products such as blood pressure monitors, infrared thermometers, nursing beds, wheelchairs, nebulizers, moxibustion series, and health protection supplies. These products cater to domestic and overseas markets, serving segments including health monitoring, rehabilitation aids, medical care, traditional Chinese medicine physiotherapy, and respiratory support. The firm's domestic market presence and international sales drive its revenue streams. The company's product portfolio includes health monitoring devices, rehabilitation aids, medical care equipment, traditional Chinese medicine physiotherapy tools, and respiratory support systems. These are sold under the Cofoe brand to both domestic and overseas customers. The firm's focus on traditional Chinese medicine physiotherapy and respiratory support systems differentiates its offerings in the medical equipment sector. Cofoe's domestic market operations and overseas business expansion contribute to its overall revenue. Cofoe Medical Technology Co., Ltd. targets customers seeking health monitoring, rehabilitation, medical care, and traditional Chinese medicine physiotherapy solutions. Its domestic market segment includes hospitals, clinics, and individual consumers, while overseas markets extend to international healthcare providers and consumers. The company's product range, from blood pressure monitors to moxibustion series, supports these segments with specialized medical equipment. Cofoe Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cofoe Medical Technology Co stock

FCF Conversion Rate (FCF/EBITDA) of Cofoe Medical Technology Co is 139.29 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Cofoe Medical Technology Co changed from 174.14 % to 139.29 %, representing a -20.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Cofoe Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Cofoe Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Cofoe Medical Technology Co

All Key Metrics — Cofoe Medical Technology Co